Application Nr Approved Date Route Status External Links
ANDA065116 None Intramuscular None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage: In Accord With The Statements In The “warning Box” The Use Of Intramuscular Bacitracin Is Limited To The Treatment Of Infants With Pneumonia And Empyema Caused By Staphylococci Shown To Be Susceptible To The Drug.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Bacitracin

Comments